NASDAQ: PHAT - Phathom Pharmaceuticals, Inc.

Yield per half year: -41.62%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Phathom Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Phathom Pharmaceuticals Inc (Phathom Pharmaceuticals) — биофармацевтическая компания, занимающаяся разработкой и коммерциализацией лекарственных средств для лечения заболеваний желудочно-кишечного тракта (ЖКТ). Компания предлагает линейку продуктов, включающую вонопразан, пероральный низкомолекулярный блокатор калия, конкурирующий с кислотой (P-CAB). Он также оценивает его вонопразан в сочетании с антибиотиками для лечения инфекции Helicobacter pylori.

more details
Он также имеет центр исследований и разработок для разработки желудочно-кишечных терапевтических средств, включая антисекреторные агенты, на рынке фармацевтической промышленности. Компания имеет свое рабочее присутствие в Соединенных Штатах, Европе и Канаде. Штаб-квартира Phathom Pharmaceuticals находится в Баффало-Гроув, штат Иллинойс, США.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2019-10-25
ISIN US71722W1071
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.phathompharma.com
Цена ао 6.62
Change price per day: 0% (6.9)
Change price per week: -0.8621% (6.96)
Change price per month: -14.81% (8.1)
Change price per 3 month: -60.3% (17.38)
Change price per half year: -41.62% (11.82)
Change price per year: -6.76% (7.4)
Change price per 3 year: -56.98% (16.04)
Change price per 5 year: -77.98% (31.34)
Change price per 10 year: 0% (6.9)
Change price per year to date: -14.81% (8.1)
All parameters

Underestimation

Title Value Grade
P/S 691.88 1
P/BV -6.49 0
P/E 0 0
EV/EBITDA -1.44 0
Total: 2.63

Efficiency

Title Value Grade
ROA, % -48.71 0
ROE, % 277.07 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.8712 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % -36.62 0
Yield EPS, % -82.49 0
Total: 2
More

Institutions Volume Share, %
Frazier Life Sciences Management, L.P. 10109279 17.29
Medicxi Ventures Management (Jersey) Ltd 3760869 6.43
Carlyle Group Inc. 3496808 5.98
Invesco Ltd. 3167653 5.42
Blackrock Inc. 2678891 4.58
Ensign Peak Advisors, Inc 2280000 3.9
NEA Management Company, LLC 1960169 3.35
Vanguard Group Inc 1956429 3.35
Avidity Partners Management, LP 1721580 2.94
Gilder, Gagnon, Howe & Co. 1455132 2.49

ETF Share, % Profitability for 1 year, % Dividends, %
Virtus LifeSci Biotech Products ETF 2.47703 36.79 0.13953
SPDR S&P Pharmaceuticals ETF 0.95686 29.8 1.29889
iShares U.S. Pharmaceuticals ETF 0.25475 6.09 1.97922
iShares Micro-Cap ETF 0.15947 17.09 1.54048
Future Tech ETF 0.12211 426.34 0.8416
Principal Healthcare Innovators ETF 0.12211 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.10564 28.58 0.8565
ProShares Ultra Nasdaq Biotechnology 0.07479 51.7 0.85651
Nuveen ESG Small-Cap ETF 0.07307 13.91 1.41019
iShares ESG Aware MSCI USA Small-Cap ETF 0.0695 18.09 1.49366
Vanguard Russell 2000 ETF 0.02 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.01735 17.47 1.51433
ProShares UltraPro Russell2000 0.01357 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01336 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01336 391.25 1.60498
Fidelity MSCI Health Care Index ETF 0.0107 3 1.46057
iShares Russell 2000 Growth ETF 0.01041 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
SPDR Portfolio MSCI Global Stock Market ETF 0.00498 17.99 2.19607
ProShares Hedge Replication ETF 0.00401 5.92 1.47892
Humankind US Stock ETF 0.00358 18.81 1.99919
Schwab U.S. Broad Market ETF 0.00134 24.86 1.43354
iShares Russell 3000 ETF 0.00114 24.83 1.43482
Avantis U.S. Equity ETF 0.00007 23.04 1.59151
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Ms. Terrie J. Curran President, CEO & Director 1.11M 1969 (56 years)
Mr. David A. Socks Co-Founder & Director 58.78k 1975 (50 years)
Dr. Azmi Nabulsi M.D., M.P.H. Co-Founder & COO 815.21k 1960 (65 years)
Ms. Molly Henderson CPA, MBA Chief Financial & Business Officer 671.27k 1971 (54 years)
Mr. Tom Harris Chief Development Sciences Officer N/A
Dr. Eckhard Leifke M.D., Ph.D. Chief Medical Officer N/A
Dr. Aditya Kohli Ph.D. Co-Founder 319.65k 1988 (37 years)
Mr. Martin J. Gilligan Chief Commercial Officer N/A
Mr. Paul Cocja Chief People Officer

Address: United States, Florham Park. NJ, 100 Campus Drive - open in Google maps, open in Yandex maps
Website: https://www.phathompharma.com